1h Free Analyst Time
The allergy immunotherapies market is forecasted to grow byUSD 1.18 billion during 2023-2028, accelerating at a CAGR of 9.62% during the forecast period. The report on the allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, recent approvals and a strong pipeline, and growing market consolidation.
The allergy immunotherapies market is segmented as below:
By Product
- SCIT
- SLIT
By Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Others
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the allergy immunotherapies market covers the following areas:
- Allergy immunotherapies market sizing
- Allergy immunotherapies market forecast
- Allergy immunotherapies market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global allergy immunotherapies market: Adamis Pharmaceuticals Corp., Aimmune Therapeutics Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLC‚ , Biomay AG, DBV Technologies SA, Desentum Oy, HAL Allergy BV, Immunomic Therapeutics Inc., Jubilant Pharmova Ltd., LETI Pharma SLU, LOFARMA Spa, Merck KGaA, Novartis AG, Optum Inc., SHIONOGI Co. Ltd., Stallergenes Greer Ltd., Torii Pharmaceutical Co. Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advances in allergy diagnostics."
According to the report, one of the major drivers for this market is the increasing prevalence of allergies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adamis Pharmaceuticals Corp.
- Aimmune Therapeutics Inc.
- ALK Abello AS
- ALLERGOPHARMA GmbH and Co. KG
- Allergy Therapeutics PLC‚
- Biomay AG
- DBV Technologies SA
- Desentum Oy
- HAL Allergy BV
- Immunomic Therapeutics Inc.
- Jubilant Pharmova Ltd.
- LETI Pharma SLU
- LOFARMA Spa
- Merck KGaA
- Novartis AG
- Optum Inc.
- SHIONOGI Co. Ltd.
- Stallergenes Greer Ltd.
- Torii Pharmaceutical Co. Ltd.
- Viatris Inc.
